Table 2 The percentage of the participants with abnormal range of sex hormones and correlation with RAS
Hormones | Case | Control | p value | ||
|---|---|---|---|---|---|
Count | % within group | Count | % within group | ||
FSH 2.5–13.2 (mIU/ml) | 6 | 20.0 | 6 | 20.0 | n.s |
LH (1–7.9 mIU/ml) | 5 | 16.7 | 4 | 13.3 | n.s |
PRL (3.5–17.9 ng/ml) | 9 | 30.0 | 8 | 26.7 | n.s |
TESTO (0.2–0.95 ng/ml) | 17 | 58.6 | 4 | 13.3 | < 0.0001 |
DHEA-S (0.37–2.71 μg/ml) | 4 | 13.8 | 1 | 3.3 | n.s |
EST (9-175 pg/ml) | 2 | 6.7 | 1 | 3.6 | n.s |
PROG (0.15–1.4 ng/ml) | 11 | 36.7 | 4 | 13.3 | 0.037 |
DHT (24-368 pg/ml) | 10 | 33.3 | 5 | 17.2 | n.s |